3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Myeloid
1
Conditions
Sarcoma
39
Dendritic Cell Sarcoma, Interdigitating
30
Lymphoma
22
Burkitt Lymphoma
22
Lymphoma, Large B-Cell, Diffuse
20
Osteosarcoma
17
Neuroectodermal Tumors, Primitive, Peripheral
17
Lymphoma, Non-Hodgkin
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia
15
Lymphoma, Large-Cell, Immunoblastic
14
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Leukemia, Myeloid, Acute
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Rhabdomyosarcoma
11
Lymphoma, B-Cell, Marginal Zone
11
Sarcoma, Ewing
10
Recurrence
10
Neuroblastoma
10
Blast Crisis
10
Leukemia, Myeloid, Accelerated Phase
9
Central Nervous System Neoplasms
9
Neoplasms, Plasma Cell
8
Myelodysplastic Syndromes
8
Multiple Myeloma
8
Leukemia, Myeloid, Chronic-Phase
8
Hodgkin Disease
8
Brain Neoplasms
8
Myeloproliferative Disorders
7
Interventions
Temozolomide
4
Surgical Procedures, Operative
3
Magnetic Resonance Spectroscopy
3
Irinotecan
2
Gadolinium DTPA
2
Donepezil
2
Carboplatin
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
temsirolimus
1
plerixafor
1
omburtamab I-131
1
gallium Ga 68 dotatate
1
gadobutrol
1
gadobenic acid
1
etoposide phosphate
1
entinostat
1
carboxyamido-triazole
1
adavosertib
1
Yoga
1
Verteporfin
1
Thiotepa
1
Thalidomide
1
Surveys and Questionnaires
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Pregabalin
1
Pharmacogenomic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pinealoma
×
Etoposide
×
Sarcoma
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled